Found 23 matching trials
Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
PHASE3To evaluate:
* the incidence of venous thromboembolic event (VTE)
* the in...
Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
PHASE1This study is a first-in-human, Phase 1/2, open label study that will evalu...
Location
University of Miami - Sylvester Comprehensive Cancer Center
Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
PHASE1Multiple myeloma (MM) is the second most common hematologic malignancy with...
Location
Multiple Locations
High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease
PHASE2The aim of the study is to assess survival of patients with advanced cardia...
Location
Centro per lo Studio e la Cura delle Amiloidosi Sistemiche - Fondazione IRCCS Policlinico S.Matteo
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE2The purpose of this study is to evaluate the efficacy and safety of talquet...
Location
University of Alabama Birmingham
First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors
PHASE1This phase 1 study is aimed at establishing the safety basis of OT-A201 in ...
Location
ICM - Montpellier
Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
NAMain objective: -To determine Human Papilloma Virus (HPV) prevalence in pat...
Location
Service de Médecine Interne - Hôpital Bichat Claude Bernard
Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients
PHASE2This study will determine whether the association of Revlimid and Prednison...
Location
Multiple Locations
Longitudinal Data Registry of Plasma Cell Dyscrasia
N/AThe goal of this multicenter observational study is to better understand th...
Location
Zhongshan Hospital, Fudan University
Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments
PHASE1This is a phase I/II multicenter, open label, nonrandomized study for patie...
Location
Pacific Oncology and Hematology